An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Leukemia
Matthew L CooperJohn F DiPersio

Abstract

T cell malignancies represent a group of hematologic cancers with high rates of relapse and mortality in patients for whom no effective targeted therapies exist. The shared expression of target antigens between chimeric antigen receptor (CAR) T cells and malignant T cells has limited the development of CAR-T because of unintended CAR-T fratricide and an inability to harvest sufficient autologous T cells. Here, we describe a fratricide-resistant "off-the-shelf" CAR-T (or UCART7) that targets CD7+ T cell malignancies and, through CRISPR/Cas9 gene editing, lacks both CD7 and T cell receptor alpha chain (TRAC) expression. UCART7 demonstrates efficacy against human T cell acute lymphoblastic leukemia (T-ALL) cell lines and primary T-ALL in vitro and in vivo without the induction of xenogeneic GvHD. Fratricide-resistant, allo-tolerant "off-the-shelf" CAR-T represents a strategy for treatment of relapsed and refractory T-ALL and non-Hodgkin's T cell lymphoma without a requirement for autologous T cells.

References

Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·M A RoguskaB C Guild
Feb 18, 1998·International Immunology·F A BonillaR S Geha
Oct 10, 1998·Journal of Virology·T DullL Naldini
Sep 15, 2000·Journal of Immunological Methods·D Campana, F G Behm
Oct 23, 2002·ILAR Journal·Michael F W Festing, Douglas G Altman
Sep 27, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John M GoldbergBarbara L Asselin
Apr 2, 2004·International Journal of Clinical Practice·N TiftikE Muftuoglu
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael P RettigJohn F DiPersio
Aug 12, 2005·Nature Methods·Shimon Gross, David Piwnica-Worms
Feb 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Carmine CarpenitoCarl H June
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Dec 17, 2014·Nature Biotechnology·Shengdar Q TsaiJ Keith Joung
Mar 26, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Linda G EissenbergJohn F DiPersio
May 15, 2015·Blood·Mark R Litzow, Adolfo A Ferrando
Jun 30, 2015·Nature Biotechnology·Ayal HendelMatthew H Porteus
Oct 28, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark J OsbornBruce R Blazar
Oct 26, 2016·Genes, Chromosomes & Cancer·Kristina Karrman, Bertil Johansson
Oct 16, 2016·International Journal of Clinical Oncology·Helen Ma, Maher Abdul-Hay
Jan 27, 2017·Science Translational Medicine·Waseem QasimPaul Veys
Feb 27, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniel T MacLeodBruce McCreedy

❮ Previous
Next ❯

Citations

Dec 12, 2018·Expert Review of Hematology·Carrie Van Der WeydenH Miles Prince
Nov 9, 2018·Clinical Pharmacology and Therapeutics·Trevor R BaybuttAdam E Snook
Jul 15, 2018·Seminars in Immunopathology·Uffe KlausenMads Hald Andersen
Jan 12, 2019·American Journal of Hematology·Waseem Qasim
Mar 19, 2019·Current Hematologic Malignancy Reports·Christine M McMahon, Selina M Luger
Mar 29, 2019·Current Oncology Reports·Paolo Strati, Sattva S Neelapu
Jul 30, 2019·Immunological Reviews·Joseph H OvedDavid T Teachey
Oct 24, 2019·Recent Patents on Anti-cancer Drug Discovery·Romeo G Mihăilă
Dec 4, 2019·Briefings in Functional Genomics·Ming ChenDi Zhu
Feb 28, 2020·Expert Review of Clinical Immunology·Caroline Diorio, David T Teachey
Jun 21, 2019·Journal of Cellular Biochemistry·Vahideh AhmadzadehHabib Zarredar
Oct 2, 2019·Cold Spring Harbor Perspectives in Medicine·Francesca GianniAdolfo Ferrando
Apr 7, 2020·Nature Reviews. Cancer·Danilo FioreGiorgio Inghirami
Apr 6, 2020·Biotechnology and Applied Biochemistry·Jiaqi Tan, Wen Yu
Dec 18, 2019·Briefings in Functional Genomics·Guillermo Ureña-BailénMarkus Mezger
May 30, 2020·Current Treatment Options in Oncology·Anand A PatelWendy Stock
Nov 13, 2019·Cold Spring Harbor Perspectives in Medicine·Yilin WuHong Wu
Mar 7, 2019·Nature Reviews. Clinical Oncology·Nirali N Shah, Terry J Fry
Jun 5, 2019·Nature Biotechnology·Stefanie R Bailey, Marcela V Maus
Dec 31, 2019·Journal of Hematology & Oncology·Lauren C FleischerSunil S Raikar
Jun 26, 2020·Frontiers in Immunology·Estefanía García-GuerreroJose Antonio Pérez-Simón
Jul 19, 2018·BMC Biotechnology·Adrián MontañoRocío Benito
Dec 26, 2018·Expert Opinion on Biological Therapy·Kejian WangHuang Zhu
Dec 10, 2019·Science China. Life Sciences·Lu WenZi-Jiang Chen
Jun 13, 2020·Current Hematologic Malignancy Reports·Andrew M Rogers, Jonathan E Brammer
Jul 13, 2018·JCI Insight·Jane RasaiyaahWaseem Qasim
Mar 14, 2019·British Journal of Haematology·Trine I JensenRasmus O Bak
Apr 4, 2019·Frontiers in Immunology·Jie LiuQi Zhao
Mar 21, 2019·Frontiers in Oncology·Lauren D SchererMaksim Mamonkin
May 7, 2019·Frontiers in Oncology·Irene ScarfòMarcela V Maus
Jun 7, 2020·Journal of Hematology & Oncology·Bachar SamraNicholas J Short
Oct 6, 2020·Frontiers in Immunology·Francesco ManfrediEliana Ruggiero
Mar 21, 2020·Signal Transduction and Targeted Therapy·Li WangWei-Li Zhao
Jun 9, 2020·ELife·Justin T GuneschEmily M Mace
Oct 16, 2018·Frontiers in Immunology·Mehmet AkceGregory B Lesinski
Oct 15, 2018·Current Hematologic Malignancy Reports·Paola GhioneMarco Ruella
Sep 21, 2018·Cancers·Teresa PoggioAnna L Illert
Oct 7, 2020·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Alexander MichelsChristian J Buchholz
Oct 22, 2020·International Journal of Molecular Sciences·Fátima Bayón-CalderónSara González-García
Oct 20, 2020·Frontiers of Medicine·Ching-Hon Pui
Dec 3, 2020·Vaccines·Robert PytlikPavel Klener
Dec 5, 2020·Hematology·Adam J Lamble, Rebecca Gardner
Jan 2, 2021·Journal of Hematology & Oncology·Katarzyna IżykowskaGrzegorz K Przybylski

❮ Previous
Next ❯

Methods Mentioned

BETA
Transfection
FACS
flow cytometry
xenograft
pull-down
PCR
GUIDE-seq
xenografts

Software Mentioned

BWA MEM
GraphPad Prism
SAS
dsODN
TreeStar
seq
DsODN capture
guide

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.